The combination of the opioid derivative trimebutine plus rizatriptan is more effective for migraine than rizatriptan alone

Source: Inpharma, Volume 1, Number 1551, 2006-08-19 , pp. 9-9(1)

Publisher: Adis International

Buy & download fulltext article:

OR

Price: $37.95 plus tax (Refund Policy)

Keywords: Migraine, treatment; Rizatriptan, therapeutic use; Trimebutine, therapeutic use

Document Type: Research article

Publication date: 2006-01-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page